MS 7.1 MasterClass: evaluated

12 April, 2019 | Posted in:

Our MS MasterClasses are well established as ‘the’ course for budding MSologists, from the foundation course for trainees and those just starting their journey in multiple sclerosis healthcare, through to our advanced course for consultants and specialists looking to deepen their specialism still further. This MS Foundation MasterClass, a delegate gave our educational course a […]

Continue Reading »

Let’s raise the bar for MS services

28 March, 2019 | Posted in:

After ‘the Way Forward’ in November 2018, it was clear that whilst variation is perhaps not the enemy we initially thought, there are nevertheless a range of challenges facing the MS community around inequity and varied quality that need addressing. It was also clear that there are an array of potential ways to move forward, […]

Continue Reading »

Proud finalists of the HSJ Partnership Awards

22 March, 2019 | Posted in:

On Wednesday night we took our place amongst a host of brilliant organisations, all working in partnership with the NHS in various ways, all shortlisted for the HSJ Partnership Awards. The awards, designed to celebrate innovative, effective partnerships between the private sector, voluntary sector and health service, covered a variety of topics including education, service […]

Continue Reading »

Brain Awareness Week 2019: multiple sclerosis

12 March, 2019 | Posted in: ,

Brain Awareness Week (BAW) coordinated by the Dana Foundation, is an opportunity for partners around the globe to share their research and educate people of all ages and backgrounds about the brain and the promise of brain research. The Neurology Academy, as neurological educators, are keen to cover as broad a picture of a condition as possible, from physiological […]

Continue Reading »

MS MasterClass project goes national

1 March, 2019 | Posted in:

Rachelle Shafei attended an MS MasterClass last year, and when selecting her intermodule project, took the opportunity to tackle an unmet need both locally and nationally – the prevention of listeriosis in MS patients receiving alemtuzumab. The disease-modifying treatment (DMT) is one of several that people with multiple sclerosis can use to slow or even […]

Continue Reading »

Why tackle variance in MS services?

15 February, 2019 | Posted in:

This final article in our Spotlight series actually features the opening presenters at our ‘the Way Forward’ event. Yet after delving into the specifics of the true cost of disease-modifying therapies (DMTs) or the way we can use data to reduce variation, it brings us full circle, back to the reasons why we need to […]

Continue Reading »

Spotlight on Blueteq data

11 February, 2019 | Posted in:

Malcolm Qualie, Pharmacy Lead for Specialised Commissioning NHS England, spoke to ‘the Way Forward’ event on Blueteq’s potential contribution to reducing variance. Outlining the landscape for pharmacological interventions in the UK, the room was reminded that, due to people living longer, more complex and innovative medicines are being developed, and more specialist medicines being used. […]

Continue Reading »

Inequalities in access to health and social care

31 January, 2019 | Posted in:

At ‘the Way Forward’ on 1-2nd November, health care professionals were specifically in attendance to tackle the problem of variance in multiple sclerosis (MS) services. As Professor Gavin Giovannoni noted when he summed up progress midway through the event, unwanted variance could just as happily be referred to as ‘inequality’ and this is what Prof […]

Continue Reading »